2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

References

Page 1

	Year	Citations
Dabigatran versus Warfarin in Patients with Atrial Fibrillation Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf, New England Journal of Medicine	2009	11.1K
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg, New England Journal of Medicine	2011	9.3K
Apixaban versus Warfarin in Patients with Atrial Fibrillation Christopher B. Granger, John H. Alexander, John J.V. McMurray, New England Journal of Medicine	2011	8.8K
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery Martin B. Leon, Craig R. Smith, Michael J. Mack, New England Journal of Medicine	2010	7.1K
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients Craig R. Smith, Martin B. Leon, Michael J. Mack, New England Journal of Medicine	2011	6.2K
Antithrombotic Therapy for VTE Disease Clive Kearon, Elie A. Akl, Anthony J. Comerota, CHEST Journal ThrombopoiesisThrombosisVenous ThrombosisHematologyPharmacotherapy	2012	6.1K
Edoxaban versus Warfarin in Patients with Atrial Fibrillation Robert P. Giugliano, Christian T. Ruff, Eugene Braunwald, New England Journal of Medicine	2013	5K
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients Martin B. Leon, Craig R. Smith, Michael J. Mack, New England Journal of Medicine	2016	4.9K
2015 ESC Guidelines for the management of infective endocarditis Gilbert Habib, Patrizio Lancellotti, Manuel J. Antunes, European Heart Journal	2015	4.9K
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease Rick A. Nishimura, Catherine M Otto, Robert O. Bonow, Journal of the American College of Cardiology Cardiovascular DiseasePatient SafetyOutcomes ResearchValve DiseaseCardiac Care	2014	3.5K

Page 1